Navigation Links
Roxane Laboratories, Inc. Announces the Launch of Naratriptan Tablets USP
Date:7/8/2010

COLUMBUS, Ohio, July 8 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Naratriptan Tablets USP, 1mg and 2.5mg by the U.S. Food and Drug Administration. The product is available in bottles of 9 for immediate shipment to wholesalers and pharmacies nationwide.

Roxane Laboratories' Naratriptan Tablets USP are AB rated to AMERGE® (naratriptan hydrochloride) tablets. Annual sales of AMERGE® are approximately $60.2 Million(1).  AMERGE® Tablets are indicated for the acute treatment of migraine attacks with or without aura in adults.

Full prescribing information for Naratriptan Tablets USP is available on the Roxane Laboratories website at www.Roxane.com or upon request by calling Roxane Laboratories Technical Product Information at

1.800.962.8364.

About Roxane Laboratories, Inc.

Roxane Laboratories is located in Columbus, OH in a modern 500,000 square foot manufacturing and laboratory facility. The facility spans 70 acres and currently employs over 1,000 people.  Currently, Roxane Laboratories markets over 80 medications in nearly 250 package sizes, focusing on an expanding line of Multisource pharmaceutical products including: bulk and unit-dose liquids and solids; coated, sustained-release and controlled-release tablets; nasal sprays, cytotoxics and CII narcotics.

Roxane Laboratories, Inc., is a subsidiary of Boehringer Ingelheim
'/>"/>

SOURCE Roxane Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Roxane Laboratories, Inc. Updated Launch of Calcium Acetate Capsules, 667mg
2. Roxane Laboratories, Inc. Announces the Launch of Anastrozole Tablets
3. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
4. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
5. Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
6. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
7. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. Provide an Update on the Aclidinium Bromide Clinical Development Program
8. Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations
9. Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
10. MO BIO Laboratories, Inc. Launches LifeGuard(TM) Soil Preservation Solution
11. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 21, 2015  TissueGene, Inc. a clinical-stage biopharmaceutical ... the field of cell therapy, today announced the ... of Chief Operating Officer.  Mr. Newman was most ... Clinical Operations at ZIOPHARM Oncology, a ... gene expression, control and cell technologies in the ...
(Date:4/21/2015)... and PARIS and BURLINGTON, N.C. , ... (NYSE: DGX ), the world,s leading provider ... National Institute of Health and Medical Research institution, ... they co-founded to provide scientists and laboratory organizations ... and BRCA2 genetic data. The program,s goal is ...
(Date:4/21/2015)... April 21, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", ... marketer of medical devices worldwide, today announced that it ... ended Mar 31, 2015 after the U.S. market closes ... earnings conference call at 8:00 AM on May 12, ... 2015 Beijing/Hong Kong Time). Dial-in details ...
Breaking Medicine Technology:TissueGene, Inc. Hires Robert Newman as Chief Operating Officer 2Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 2Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 3Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 4Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 5Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 6Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 7Mindray to Report 2015 First Quarter Financial Results on May 11, 2015 2
... May 9 Osteoarthritis is a,painful and ... people in the United States. It is ... The novel investigational pain medication,tapentadol, a centrally ... with joint-disease pain, compared to those treated ...
... Biosciences, Inc.,(Nasdaq: RDEA ), a company focused ... for the treatment of HIV, cancer and,inflammatory diseases, ... been appointed Senior Vice President, Finance and Operations ... will resign from our board of,directors shortly thereafter. ...
Cached Medicine Technology:Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6
(Date:4/21/2015)... York, NY (PRWEB) April 21, 2015 What ... Jessica Parker, Tom Ford and Ted Turner have in common? ... of the 50 Most Powerful Americans 50+. In a 16-page ... Chief of more than 50 magazines and 25 websites, along ... on the power they wield through the unique lens of ...
(Date:4/21/2015)... 21, 2015 Zane Benefits, a software ... its CEO Rick Lindquist has been selected as one ... According to Rick Lindquist, “There is a massive shift ... Benefits’ small business solutions are at its forefront. Our ... Employee Benefit Adviser’s Rising Stars.” , According to the ...
(Date:4/21/2015)... Let's face it; a lot of skin ... and complex routines for hundreds of dollars. Block ... gimmicks, as the sun is the leading cause of skin ... more than just daily sun protection; it is also about ... new Purifying Facial Cleanser and Revitalizing Night ...
(Date:4/21/2015)... April 21, 2015 Quark Software ... a new knowledge management solution that enables large ... of policies and procedures. With Quark Procedure Management, ... content that is easy to save, search and ... to risk and compliance issues. Examples of policies ...
(Date:4/21/2015)... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology ... report results for the first quarter of 2015 on ... market. , The Company will host a conference ... release at 4:30 PM ET. Investors interested in ... at 1.877.407.0993 or use the direct dial-in number 1.201.689.8795. ...
Breaking Medicine News(10 mins):Health News:NiC 50: 2015 Ranking of the Most Powerful Americans 50+ 2Health News:NiC 50: 2015 Ranking of the Most Powerful Americans 50+ 3Health News:NiC 50: 2015 Ranking of the Most Powerful Americans 50+ 4Health News:Zane Benefits’ CEO Named Top 20 Rising Stars 2Health News:Block Island Organics Debunks Skin Care Myths with New Products 2Health News:Block Island Organics Debunks Skin Care Myths with New Products 3Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 3Health News:AxoGen, Inc. to Report First Quarter Financial Results on May 5, 2015 2
... Fla. October 24, 2011 Patients in the United ... able to benefit from a new treatment that is already ... The treatment, called collagen crosslinking, improved vision in almost 70 ... clinical trial in Milan, Italy. The treatment is in clinical ...
... Heavy alcohol consumption may be linked to a ... and increased consumption of black tea and fruit are ... three separate studies presented at CHEST 2011, the 77th ... (ACCP), heavy alcohol consumption was related to increased risk ...
... Lung Cancer Mortality Rates , (#1111771, Tuesday, October ... has one of the highest mortality rates in the ... on data from the National Cancer Institute Surveillance, Epidemiology, ... Regional Medical Center in Flint, Michigan and the Mayo ...
... training on a take-home simulator do a better job once ... told the Canadian Cardiovascular Congress 2011, co-hosted by the Heart ... Dr. Lam and a multidisciplinary surgical team developed a kit ... be taken home by trainees to practice a highly technical ...
... reconstruction with tissue from their own abdomen experience significant ... as three weeks after surgery. That is one of ... in Cancer , a peer-reviewed journal of the ... to breast cancer survivors who are contemplating these types ...
... -- While there are challenges, Halloween can still be fun ... enjoy Halloween and enjoy some of the sweets the holiday ... and senior scientist at the University of Alabama at Birmingham ... "We give parents and kids three options and let them ...
Cached Medicine News:Health News:Vitamin B-based treatment for corneal disease may offer some patients a permanent solution 2Health News:Heavy alcohol consumption linked to lung cancer 2Health News:CHEST 2011: Embargoed studies highlight new lung cancer and COPD research 2Health News:CHEST 2011: Embargoed studies highlight new lung cancer and COPD research 3Health News:Heart surgeons-in-training benefit from hands-on homework 2Health News:Advanced post-mastectomy breast reconstruction improves women's psychosocial and sexual well-being 2Health News:Healthy Halloween Advice for Children With Diabetes 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: